Mallon PWG - Search Results

1

Inflammatory Phenotypes Predict Changes in Arterial Stiffness Following Antiretroviral Therapy Initiation.

Kelly C, Tinago W, Alber D, Hunter P, Luckhurst N, Connolly J, Arrigoni F, Abner AG, Kamngona R, Sheha I, Chammudzi M, Jambo K, Mallewa J, Rapala A, Heyderman RS, Mallon PWG, Mwandumba H, Walker AS, Klein N, Khoo S. Kelly C, et al. Among authors: mallon pwg. Clin Infect Dis. 2020 Dec 3;71(9):2389-2397. doi: 10.1093/cid/ciaa186. Clin Infect Dis. 2020. PMID: 32103268 Free PMC article.

2

Characterization of associations and development of atazanavir resistance after unplanned treatment interruptions.

Tinago W, O'Halloran JA, O'Halloran RM, Macken A, Lambert JS, Sheehan GJ, Mallon PW. Tinago W, et al. HIV Med. 2014 Apr;15(4):224-32. doi: 10.1111/hiv.12107. Epub 2013 Nov 12. HIV Med. 2014. PMID: 24215370 Free article.

3

Clinical, immunological and treatment-related factors associated with normalised CD4+/CD8+ T-cell ratio: effect of naïve and memory T-cell subsets.

Tinago W, Coghlan E, Macken A, McAndrews J, Doak B, Prior-Fuller C, Lambert JS, Sheehan GJ, Mallon PW; Mater Immunology Study Group. Tinago W, et al. PLoS One. 2014 May 9;9(5):e97011. doi: 10.1371/journal.pone.0097011. eCollection 2014. PLoS One. 2014. PMID: 24816636 Free PMC article.

4

Maraviroc, as a Switch Option, in HIV-1-infected Individuals With Stable, Well-controlled HIV Replication and R5-tropic Virus on Their First Nucleoside/Nucleotide Reverse Transcriptase Inhibitor Plus Ritonavir-boosted Protease Inhibitor Regimen: Week 48 Results of the Randomized, Multicenter MARCH Study.

Pett SL, Amin J, Horban A, Andrade-Villanueva J, Losso M, Porteiro N, Sierra Madero J, Belloso W, Tu E, Silk D, Kelleher A, Harrigan R, Clark A, Sugiura W, Wolff M, Gill J, Gatell J, Fisher M, Clarke A, Ruxrungtham K, Prazuck T, Kaiser R, Woolley I, Arnaiz JA, Cooper D, Rockstroh JK, Mallon P, Emery S; Maraviroc Switch (MARCH) Study Group. Pett SL, et al. Clin Infect Dis. 2016 Jul 1;63(1):122-32. doi: 10.1093/cid/ciw207. Epub 2016 Apr 5. Clin Infect Dis. 2016. PMID: 27048747 Free PMC article. Clinical Trial.

5

Predictors of longitudinal change in bone mineral density in a cohort of HIV-positive and negative patients.

Tinago W, Cotter AG, Sabin CA, Macken A, Kavanagh E, Brady JJ, McCarthy G, Compston J, Mallon PW; HIV UPBEAT Study Group. Tinago W, et al. AIDS. 2017 Mar 13;31(5):643-652. doi: 10.1097/QAD.0000000000001372. AIDS. 2017. PMID: 28060010

6

The HIV Care Cascade and sub-analysis of those linked to but not retained in care: the experience from a tertiary HIV referral service in Dublin Ireland.

McGettrick P, Ghavami-Kia B, Tinago W, Macken A, O'Halloran J, Lambert JS, Sheehan G, Mallon PWG. McGettrick P, et al. Among authors: mallon pwg. HIV Clin Trials. 2017 May;18(3):93-99. doi: 10.1080/15284336.2017.1298317. Epub 2017 Mar 14. HIV Clin Trials. 2017. PMID: 28290773

7

Switching from abacavir to tenofovir disoproxil fumarate is associated with rises in soluble glycoprotein VI, suggesting changes in platelet-collagen interactions.

O'Halloran JA, Dunne E, Tinago W, Denieffe S, Kenny D, Mallon PWG. O'Halloran JA, et al. Among authors: mallon pwg. AIDS. 2018 Apr 24;32(7):861-866. doi: 10.1097/QAD.0000000000001783. AIDS. 2018. PMID: 29438200 Clinical Trial.

8

Plasma nucleotide reverse transcriptase inhibitor concentration and their associations with liver and renal parameters in people living with HIV.

Wang X, Boffito M, Dickinson L, Bagkeris E, Khoo S, Post FA, Vera J, Williams I, Ndoutoumou A, Anderson J, Mallon P, McClure M, Winston A, Sabin C; POPPY Study. Wang X, et al. AIDS. 2020 Apr 1;34(5):790-793. doi: 10.1097/QAD.0000000000002479. AIDS. 2020. PMID: 32167992

9

Interferon lambda rs368234815 ΔG/ΔG is associated with higher CD4⁺:CD8⁺ T-cell ratio in treated HIV-1 infection.

Freitas IT, Tinago W, Sawa H, McAndrews J, Doak B, Prior-Fuller C, Sheehan G, Lambert JS, Muldoon E, Cotter AG, Hall WW, Mallon PWG, Carr MJ. Freitas IT, et al. Among authors: mallon pwg. AIDS Res Ther. 2020 Apr 15;17(1):13. doi: 10.1186/s12981-020-00269-0. AIDS Res Ther. 2020. PMID: 32295609 Free PMC article.

10

Investigating the effect of antiretroviral switch to tenofovir alafenamide on lipid profiles in people living with HIV.

Lacey A, Savinelli S, Barco EA, Macken A, Cotter AG, Sheehan G, Lambert JS, Muldoon E, Feeney E, Mallon PW, Tinago W; UCD ID Cohort Study. Lacey A, et al. AIDS. 2020 Jul 1;34(8):1161-1170. doi: 10.1097/QAD.0000000000002541. AIDS. 2020. PMID: 32310899

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

174 results

Search Page